Riskpilot← Back to searchSign inGet full accessMEDU HOLDING AS
ASActiveOrg 926695207Lilleakerveien 2B, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-687% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
NOK -1,2M
-691% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1,2M | -687% |
| Net profit | NOK -1,2M | -691% |
| Total assets | NOK 146,4M | -27% |
| Equity | NOK 144,4M | -28% |
| Employees | 0 | — |
Legal name
MEDU HOLDING AS
Org number
926695207
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. mars 2021
Share capital
NOK 4 489 287
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å investere direkte eller indirekte i selskaper relatert til helsesektoren eller livsvitenskap, herunder gjennom deltagelse i hel- eller deleide selskaper eller andre sammenslutninger eller investeringer i andre finansielle instrumenter som direkte eller indirekte kan være egnet til å gi selskapet tilgang til investeringer relatert til helsesektoren, samt alt som står i forbindelse med dette.
Address
Lilleakerveien 2B, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −34 | −429 | −147 | −1 160 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −34 | −429 | −147 | −1 160 |
| Net financials | −10 | 0 | 0 | −5 |
| Profit before tax | −44 | −429 | −147 | −1 165 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −44 | −429 | −147 | −1 165 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 76 315 | 99 509 | 201 135 | 146 404 |
| Equity | 76 236 | 99 509 | 201 113 | 144 403 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 80 | 0 | 22 | 2 001 |
| Total debt | 80 | 0 | 22 | 2 001 |
EBITDA margin
-115988200.0%
This company
15.8%
Market median
-734102632% vs market
20212024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20212024
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20212024
Net profit margin
-116471500.0%
This company
8.1%
Market median
-1437919853% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 89.49% | 89.49% | 2024 | |
Rönnhold Oy | Company | 4.52% | 4.52% | 2023 |
Rnnhold Oy | Company | 2.96% | 2.96% | 2024 |
Åkersbrot Mt Ab | Company | 2.69% | 2.69% | 2024 |
Turmidas Ab | Company | 2.42% | 2.42% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
As Clipper
MEDU HOLDING AS Board members of MEDU HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christopher Segtnan Tangen | Chairman | 0 companies |
| Magne Stoknes | Board of Directors | 0 companies |
| Petter Solum | Board of Directors | 0 companies |
| Michael Bodd | Board of Directors | 0 companies |
| Synne Hermansen Røine | Chairman | 0 companies |